IBX vs IPD

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

IBX

IMAGIONBIO FPO [IBX]

28LOW

IPD

IMPEDIMED FPO [IPD]

48LOW

Score Breakdown

IBX IPD
Technical
35
57
Catalyst
53
55
Sentiment
50
50
Fundamental
17
95
Momentum
25
30
Risk Gate
27
27

Key Metrics

IBX Metric IPD
$6.5MMarket Cap$22.0M
2.6MAvg Volume (20d)6.9M
N/AShort InterestN/A
$0.05552-Week High$0.059
$0.01152-Week Low$0.005
+0.0%Daily Change+0.0%
$0.011Reference Price$0.006
N/AROE-117.9%
N/AProfit Margin-171.3%

Active Signals

IBX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Above-average volume (1.8x) on a red day — sellers in control
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Sitting near support — this level has held before and could attract buyers again
Took a hit — down 15.4% over the last 5 days

IPD Signals

Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (5 quarters)
Low P/S ratio (1.5x)
Strong revenue growth (+25%)
Piotroski F-Score weak (3/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Near 52-week low (2% of range)

Ask Scout AI to compare IBX and IPD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IBX vs MEM →IBX vs NEU →IBX vs PHX →IBX vs PYC →IBX vs RCE →
IBX Full Analysis → IPD Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).